Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder

ClinicalTrials.gov ID: NCT00928070

Public ClinicalTrials.gov record NCT00928070. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 2:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine Flexible Dose Regimen In Vulnerable Elderly Patients With Overactive Bladder.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to assess the efficacy and safety of a flexible dose regimen of fesoterodine on urgency urinary incontinence (UUI) episodes in vulnerable elderly subjects with overactive bladder (OAB).

Study identification

NCT ID
NCT00928070
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
566 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
65 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2009 (Type not available)
Primary completion
Sep 2011 (Actual)
Completion
Sep 2011 (Actual)
Last update posted
Jan 17, 2013

2009 – 2011

United States locations

U.S. sites
125
U.S. states
35
U.S. cities
109
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35233 —
Pfizer Investigational Site Birmingham Alabama 35294 —
Pfizer Investigational Site Montgomery Alabama 36117 —
Pfizer Investigational Site Green Valley Arizona 85614 —
Pfizer Investigational Site Mesa Arizona 85206-1734 —
Pfizer Investigational Site Phoenix Arizona 85032 —
Pfizer Investigational Site Tucson Arizona 85712 —
Pfizer Investigational Site Tuscon Arizona 85710 —
Pfizer Investigational Site Little Rock Arkansas 72204 —
Pfizer Investigational Site Little Rock Arkansas 72223 —
Pfizer Investigational Site Costa Mesa California 92626 —
Pfizer Investigational Site Fairfield California 94534 —
Pfizer Investigational Site Glendora California 91741 —
Pfizer Investigational Site La Mesa California 91942 —
Pfizer Investigational Site Long Beach California 90806 —
Pfizer Investigational Site Mission Viejo California 92691 —
Pfizer Investigational Site Murrieta California 92562 —
Pfizer Investigational Site Norwalk California 90650 —
Pfizer Investigational Site Paramount California 90723 —
Pfizer Investigational Site Rancho Santa Margarita California 92688 —
Pfizer Investigational Site San Bernardino California 92404 —
Pfizer Investigational Site San Diego California 92108 —
Pfizer Investigational Site Santa Ana California 92705 —
Pfizer Investigational Site Temecula California 92591 —
Pfizer Investigational Site Vacaville California 95688 —
Pfizer Investigational Site Aurora Colorado 80012 —
Pfizer Investigational Site Colorado Springs Colorado 80907 —
Pfizer Investigational Site Colorado Springs Colorado 80909 —
Pfizer Investigational Site Denver Colorado 80211 —
Pfizer Investigational Site Denver Colorado 80220 —
Pfizer Investigational Site Englewood Colorado 80110 —
Pfizer Investigational Site Englewood Colorado 80113 —
Pfizer Investigational Site Longmont Colorado 80501 —
Pfizer Investigational Site Parker Colorado 80134 —
Pfizer Investigational Site Groton Connecticut 06340 —
Pfizer Investigational Site Milford Connecticut 06460 —
Pfizer Investigational Site New London Connecticut 06320 —
Pfizer Investigational Site Bonita Springs Florida 34134 —
Pfizer Investigational Site Boynton Beach Florida 33472 —
Pfizer Investigational Site Brooksville Florida 34601 —
Pfizer Investigational Site Clearwater Florida 33756 —
Pfizer Investigational Site Daytona Beach Florida 32114 —
Pfizer Investigational Site DeLand Florida 32720 —
Pfizer Investigational Site Fort Lauderdale Florida 33316 —
Pfizer Investigational Site Lake Worth Florida 33461 —
Pfizer Investigational Site Melbourne Florida 32901 —
Pfizer Investigational Site Naples Florida 34102 —
Pfizer Investigational Site New Port Richey Florida 34652 —
Pfizer Investigational Site New Port Richey Florida 34655 —
Pfizer Investigational Site Ocala Florida 34471 —
Pfizer Investigational Site Plant City Florida 33563 —
Pfizer Investigational Site Sarasota Florida 34237 —
Pfizer Investigational Site St. Petersburg Florida 33710 —
Pfizer Investigational Site Trinity Florida 34655 —
Pfizer Investigational Site Wellington Florida 33449 —
Pfizer Investigational Site Winter Haven Florida 33880 —
Pfizer Investigational Site Atlanta Georgia 30067 —
Pfizer Investigational Site Macon Georgia 31217 —
Pfizer Investigational Site Springfield Illinois 62702 —
Pfizer Investigational Site Springfield Illinois 62703 —
Pfizer Investigational Site Newburgh Indiana 47630 —
Pfizer Investigational Site Arkansas City Kansas 67005 —
Pfizer Investigational Site Kansas City Kansas 66160-7390 —
Pfizer Investigational Site Wichita Kansas 67205 —
Pfizer Investigational Site Wichita Kansas 67207 —
Pfizer Investigational Site Lexington Kentucky 40503 —
Pfizer Investigational Site Lexington Kentucky 40504 —
Pfizer Investigational Site Shreveport Louisiana 71106 —
Pfizer Investigational Site Baltimore Maryland 21211 —
Pfizer Investigational Site Glen Burnie Maryland 21061 —
Pfizer Investigational Site Towson Maryland 21204 —
Pfizer Investigational Site Springfield Massachusetts 01103 —
Pfizer Investigational Site Grand Rapids Michigan 49503 —
Pfizer Investigational Site Kalamazoo Michigan 49009 —
Pfizer Investigational Site Edina Minnesota 55435 —
Pfizer Investigational Site Picayune Mississippi 39466 —
Pfizer Investigational Site Southaven Mississippi 38671 —
Pfizer Investigational Site St Louis Missouri 63117 —
Pfizer Investigational Site Lincoln Nebraska 68516 —
Pfizer Investigational Site Omaha Nebraska 68114 —
Pfizer Investigational Site Las Vegas Nevada 89119 —
Pfizer Investigational Site Moorestown New Jersey 08057 —
Pfizer Investigational Site Sewell New Jersey 08080 —
Pfizer Investigational Site Albany New York 12208 —
Pfizer Investigational Site Brooklyn New York 11215 —
Pfizer Investigational Site Staten Island New York 10304 —
Pfizer Investigational Site Williamsville New York 14221 —
Pfizer Investigational Site Cary North Carolina 27511 —
Pfizer Investigational Site Cary North Carolina 27518 —
Pfizer Investigational Site Raleigh North Carolina 27612 —
Pfizer Investigational Site Willoughby Hills Ohio 44094 —
Pfizer Investigational Site Bethany Oklahoma 73008 —
Pfizer Investigational Site Norman Oklahoma 73069 —
Pfizer Investigational Site Oklahoma City Oklahoma 73109 —
Pfizer Investigational Site Oklahoma City Oklahoma 73112 —
Pfizer Investigational Site Portland Oregon 97205 —
Pfizer Investigational Site Altoona Pennsylvania 16602 —
Pfizer Investigational Site Erie Pennsylvania 16507 —
Pfizer Investigational Site Pittsburgh Pennsylvania 15243 —
Pfizer Investigational Site East Providence Rhode Island 02914 —
Pfizer Investigational Site East Providence Rhode Island 02915 —
Pfizer Investigational Site Charleston South Carolina 29425 —
Pfizer Investigational Site Columbia South Carolina 29201 —
Pfizer Investigational Site Myrtle Beach South Carolina 29572 —
Pfizer Investigational Site Bristol Tennessee 37620 —
Pfizer Investigational Site Chattanooga Tennessee 37404 —
Pfizer Investigational Site Jackson Tennessee 38305 —
Pfizer Investigational Site Memphis Tennessee 38119 —
Pfizer Investigational Site Austin Texas 78745 —
Pfizer Investigational Site Austin Texas 78757 —
Pfizer Investigational Site Corpus Christi Texas 78414 —
Pfizer Investigational Site Houston Texas 77062 —
Pfizer Investigational Site Houston Texas 77074 —
Pfizer Investigational Site Leander Texas 78641 —
Pfizer Investigational Site Longview Texas 75601 —
Pfizer Investigational Site Longview Texas 75605 —
Pfizer Investigational Site San Antonio Texas 78216 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site Temple Texas 76508 —
Pfizer Investigational Site Murray Utah 84107 —
Pfizer Investigational Site Salt Lake City Utah 84103 —
Pfizer Investigational Site West Jordan Utah 84088 —
Pfizer Investigational Site Richmond Virginia 23229 —
Pfizer Investigational Site Burien Washington 98166 —
Pfizer Investigational Site Spokane Washington 99216 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00928070, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 17, 2013 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00928070 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →